Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia, Focusing on Long Term Cytopenias Before and After the Era of Targeted Therapies

The widespread application of fludarabine, cyclophosphamide, and rituximab combination is limited due to its toxicity, particularly the prolonged cytopenias. The study aimed to compare the prolonged cytopenias depending on fitness and report real-life data on dose reduction measures and efficacy. Ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Szász, Róbert, Telek, Béla, Illés, Árpád
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Society Journal Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262186/
https://www.ncbi.nlm.nih.gov/pubmed/34257611
http://dx.doi.org/10.3389/pore.2021.1609742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262186/
https://www.ncbi.nlm.nih.gov/pubmed/34257611
http://dx.doi.org/10.3389/pore.2021.1609742

Ejemplares similares